OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 6, 2025, 5:14 PM EDT
OpGen Revenue
OpGen had revenue of $5.03M in the twelve months ending March 31, 2025, up 88.10% year-over-year. In the year 2024, OpGen had annual revenue of $5.20M with 52.01% growth.
Revenue (ttm)
5.03M
Revenue Growth
+88.10%
P/S Ratio
0.00
Revenue / Employee
5.03M
Employees
1
Market Cap
1.01K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.20M | 1.78M | 52.01% |
Dec 31, 2023 | 3.42M | 811.03K | 31.11% |
Dec 31, 2022 | 2.61M | -1.70M | -39.45% |
Dec 31, 2021 | 4.31M | 91.59K | 2.17% |
Dec 31, 2020 | 4.21M | 715.83K | 20.46% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Jushi Holdings | 256.36M |
Nuo Therapeutics | 1.95M |
OpGen News
- 1 year ago - OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q - GlobeNewsWire
- 1 year ago - OpGen Announced 1-for-10 Reverse Stock Split - GlobeNewsWire
- 1 year ago - OpGen Provides Update on Business Operations and Strategic Opportunities - GlobeNewsWire
- 1 year ago - OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K - GlobeNewsWire
- 1 year ago - OpGen Announces Acquisition of Preferred Stock by David Lazar - GlobeNewsWire
- 2 years ago - OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 2 years ago - OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds - GlobeNewsWire
- 2 years ago - OpGen, Inc. (OPGN) Q2 2023 Earnings Call Transcript - Seeking Alpha